You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Correction: Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

https://doi.org/10.1136/rmdopen-2018-000809corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Lauper K, Mongin D, Iannone F, et al. Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. RMD Open 2018;4:e000809. doi: 10.1136/rmdopen-2018-000809.

    The article has been corrected since it was published online. The values in the second row “Total patient-years” of table 1 have been amended and the supplement file has been updated to support the same.